Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix-Reference-Cited by-同舟云学术

Tissue factor pathway inhibitor‑2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix

Published:2021-01-20 Issue:3 Volume:45 Page:1023-1032
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Ota Yukihide¹^ORCID,Koizume Shiro¹,Nakamura Yoshiyasu¹,Yoshihara Mitsuyo¹,Takahashi Tomoko¹,Sato Shinya¹,Myoba Shohei²,Ohtake Norihisa²,Kato Hisamori³,Yokose Tomoyuki⁴,Miyagi Etsuko⁵,Miyagi Yohei¹

Affiliation:

1. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama 241‑8515, Japan

2. Bioscience Division, Reagent Development Department, Tosoh Corporation, Ayase, Kanagawa 252‑1123, Japan

3. Department of Gynecologic Oncology, Kanagawa Cancer Center, Yokohama 241‑8515, Japan

4. Department of Pathology, Kanagawa Cancer Center, Yokohama 241‑8515, Japan

5. Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama 236‑0004, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue factor pathway inhibitor 2 as a serum biomarker for endometrial cancer: a single-center retrospective study;BMC Cancer;2024-08-27

2. Tissue factor pathway inhibitor-2 (TFPI-2)—an underappreciated partaker in cancer and metastasis;Cancer and Metastasis Reviews;2024-08-17

3. Dual Role of Tissue Factor Pathway Inhibitor 2—A Novel Serodiagnostic Marker for Ovarian Cancer—In Human Cancers;International Journal of Translational Medicine;2024-06-28

4. Investigating the efficacy of tissue factor pathway inhibitor‑2 as a promising prognostic marker for ovarian cancer;Oncology Letters;2024-05-08

5. Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer;Oncology Letters;2023-09-13